Key Trends and Insights into the Androgenetic Alopecia Treatment Market: Growth Rate and Opportunities to 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the androgenetic alopecia treatment market grown over the years?
The androgenetic alopecia treatment market has experienced strong growth in recent years. It will increase from $2.29 billion in 2024 to $2.47 billion in 2025, at a compound annual growth rate (CAGR) of 7.9%. The growth is linked to the emphasis on improving patient outcomes, the rise in the geriatric population, and increasing healthcare expenditure.
What Is the forecasted market size and growth rate for the androgenetic alopecia treatment market?
The androgenetic alopecia treatment market is expected to grow strongly, reaching $3.3 billion by 2029 with a CAGR of 7.5%. Growth is attributed to the increasing prevalence of hair loss, chronic diseases such as cancer and PCOS, and demand for effective hair loss solutions. Trends include product partnerships, approvals, investments, and ongoing research and development.
Get your androgenetic alopecia treatment market report here!
What are the major factors driving growth in the androgenetic alopecia treatment market?
The increasing incidence of hair loss is expected to drive the growth of the androgenetic alopecia treatment market. Androgenetic alopecia, a common form of hair loss, is influenced by genetics, hormonal changes, stress, and nutritional deficiencies. Treatments aim to regulate hormones, stimulate hair follicles, and promote regrowth. For example, in March 2022, the Hair Society reported that 21 million women and 35 million men worldwide suffer from hair loss. In the UK, approximately 8 million women and 6.5 million men are affected by hair loss, with over 650,000 hair transplants performed annually. The growing prevalence of hair loss is contributing to the expansion of the androgenetic alopecia treatment market.
What key areas define the segmentation of the global androgenetic alopecia treatment Market?
The androgenetic alopecia treatment market covered in this report is segmented –
1) By Treatment Type: Pharmaceutical, Device
2) By Medication Type: Prescription, Over-The-Counter
3) By Gender: Male, Female
4) By End-User: Homecare Settings, Dermatology, Clinics, Other End-Users
Subsegments:
1) By Pharmaceutical: Oral Medications ( Finasteride), Topical Medications (Minoxidil), Hormonal Therapy
2) By Device: Laser Therapy Devices, Hair Transplant Devices, Scalp Micropigmentation Devices
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15721&type=smp
What are the top market players propelling the growth of the androgenetic alopecia treatment industry?
Major companies operating in the androgenetic alopecia treatment market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eli Lilly and Company, Daiichi-Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Allergan Plc, Aurobindo Pharma Limited, Dr Reddy’s Laboratories Ltd., Cipla Limited, Fagron Inc., Vitabiotics Ltd., Cosmo Pharmaceuticals NV, Aclaris Therapeutics Inc., Curallux LLC, PureTech Health, Technoderma Medicines Inc., Theradome Inc., Lexington International, HCell Inc., Follica Inc., Ranbaxy Laboratories Ltd., Apira Science Inc., Freedom Laser Therapy Inc., Histogen Inc.
What are the key trends shaping the future of the androgenetic alopecia treatment market?
Companies in the androgenetic alopecia treatment market are developing drugs that promote hair follicle regeneration, inhibit hair-loss-causing hormones, and use novel delivery systems such as topical treatments and oral medications. For instance, in June 2023, Pfizer Inc., a US-based healthcare company, received FDA approval for LITFULO (ritlecitinib), an oral treatment for severe alopecia areata in individuals aged 12 and older. LITFULO is a kinase inhibitor that blocks JAK3 and TEC family kinases. The FDA’s approval was based on the ALLEGRO trial, where 23% of patients using LITFULO achieved 80% scalp hair coverage after six months, offering a new treatment option for alopecia areata.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15721
What regions are dominating the androgenetic alopecia treatment market growth?
North America was the largest region in the androgenetic alopecia treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgenetic alopecia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Neutropenia Biologic Drug Treatment Global Market Report 2024
Alopecia Areata Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alopecia-areata-global-market-report
Psoriatic Arthritis Treatment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
